SPARQL
Downloads
Documentation/Help
Skip Header
Results
Your Query
Add common prefixes
DESCRIBE <http://purl.uniprot.org/SHA-384/076F7F2F26B2A985DD11DEC4BD0AFF1FA4DD56C0C3E5D1CE999EC1A637EC58230A0D715663FCFAD96BB594F583D4C7C8>
Submit Query
Cancel
RDF/XML
NTriples
Turtle
Show query
Share
Subject
Predicate
Object
http://purl.uniprot.org/SHA-384/076F7F2F26B2A985DD11DEC4BD0AFF1FA4DD56C0C3E5D1CE999EC1A637EC58230A0D715663FCFAD96BB594F583D4C7C8
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/076F7F2F26B2A985DD11DEC4BD0AFF1FA4DD56C0C3E5D1CE999EC1A637EC58230A0D715663FCFAD96BB594F583D4C7C8
http://www.w3.org/2000/01/rdf-schema#comment
"FBP1 knockdown decreases ovarian cancer formation and cisplatin resistance through EZH2-mediated H3K27me3."
xsd:string
http://purl.uniprot.org/uniprot/#_8CC7EEE96A3A51C2677049BB05134F880392A3FFF949D9574A7D9DFF5B80BE21DA4FBC75F3F8211A430F3CE0D1660025
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
http://purl.uniprot.org/SHA-384/076F7F2F26B2A985DD11DEC4BD0AFF1FA4DD56C0C3E5D1CE999EC1A637EC58230A0D715663FCFAD96BB594F583D4C7C8
http://purl.uniprot.org/uniprot/Q9QXC3
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/076F7F2F26B2A985DD11DEC4BD0AFF1FA4DD56C0C3E5D1CE999EC1A637EC58230A0D715663FCFAD96BB594F583D4C7C8
http://purl.uniprot.org/uniprot/#_Q9QXC3-mappedCitation-36000567
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/076F7F2F26B2A985DD11DEC4BD0AFF1FA4DD56C0C3E5D1CE999EC1A637EC58230A0D715663FCFAD96BB594F583D4C7C8